| P50 | author | David Meyerholz | Q42482570 |
| | Annette J Schlueter | Q56871026 |
| P2093 | author name string | Alicia K Olivier | |
| | Sabrina M Scroggins | |
| P2860 | cites work | Novel treatment concepts for graft-versus-host disease | Q26860139 |
| | PD-1 and its ligands in tolerance and immunity | Q28131650 |
| | The role of the PD-1 pathway in autoimmunity and peripheral tolerance | Q28304161 |
| | Impaired dendritic cell maturation and increased T(H)2 responses in PIR-B(-/-) mice | Q28594197 |
| | Immunobiology of dendritic cells | Q29547465 |
| | Regulatory dendritic cells protect against cutaneous chronic graft-versus-host disease mediated through CD4+CD25+Foxp3+ regulatory T cells | Q80768332 |
| | Regulatory dendritic cells protect against allergic airway inflammation in a murine asthmatic model | Q81405725 |
| | Regulatory dendritic cells act as regulators of acute lethal systemic inflammatory response | Q82252356 |
| | Graft-versus-host disease | Q83468020 |
| | Overexpression of programmed death ligand 1 in dendritic cells inhibits allogeneic lymphocyte activation in mice | Q83548887 |
| | Prevention of Murine Acute Graft-versus-Host Disease by Recipient-Derived Paired Immunoglobulin-Like Receptor B Lentivirus-Transfected Dendritic Cells | Q85111644 |
| | Impact of graft-versus-host disease on survival | Q33379742 |
| | Regulatory T cells and human myeloid dendritic cells promote tolerance via programmed death ligand-1. | Q33528964 |
| | A previously unrecognized H-2D(b)-restricted peptide prominent in the primary influenza A virus-specific CD8(+) T-cell response is much less apparent following secondary challenge | Q33801952 |
| | CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease | Q33980867 |
| | Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders. | Q34015933 |
| | Advances in graft-versus-host disease biology and therapy | Q34031916 |
| | Loss of cystic fibrosis transmembrane conductance regulator function produces abnormalities in tracheal development in neonatal pigs and young children | Q34402437 |
| | TGF-beta1 treated murine dendritic cells are maturation resistant and down-regulate Toll-like receptor 4 expression | Q34423175 |
| | Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses | Q34650346 |
| | Control of regulatory T cell lineage commitment and maintenance | Q34658594 |
| | B7-1/2, but not PD-L1/2 molecules, are required on IL-10-treated tolerogenic DC and DC-derived exosomes for in vivo function. | Q34788681 |
| | Enhanced allostimulatory activity of host antigen-presenting cells in old mice intensifies acute graft-versus-host disease | Q34791351 |
| | Roles of CD28, CTLA4, and inducible costimulator in acute graft-versus-host disease in mice | Q35092307 |
| | Mechanisms of antigen presentation to T cells in murine graft-versus-host disease: cross-presentation and the appearance of cross-presentation | Q35608178 |
| | Vasoactive intestinal peptide induces regulatory dendritic cells that prevent acute graft-versus-host disease while maintaining the graft-versus-tumor response | Q35849658 |
| | Paired immunoglobulin-like receptors and their MHC class I recognition | Q36191190 |
| | Biochemical nature and cellular distribution of the paired immunoglobulin-like receptors, PIR-A and PIR-B | Q36367933 |
| | Cooperative B7-1/2 (CD80/CD86) and B7-DC costimulation of CD4+ T cells independent of the PD-1 receptor | Q36376676 |
| | A critical role for the programmed death ligand 1 in fetomaternal tolerance | Q36403162 |
| | Factors affecting human T cell engraftment, trafficking, and associated xenogeneic graft-vs-host disease in NOD/SCID beta2mnull mice. | Q36453843 |
| | PD-1 and its ligands in T-cell immunity | Q36791446 |
| | Tolerogenic dendritic cells and the quest for transplant tolerance | Q36879029 |
| | Risk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemia | Q37104236 |
| | Acute graft-versus-host disease: differing risk with differing graft sources and conditioning intensity | Q37173459 |
| | Host APCs augment in vivo expansion of donor natural regulatory T cells via B7H1/B7.1 in allogeneic recipients | Q37206377 |
| | Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses | Q37416103 |
| | Development and functional specialization of CD103+ dendritic cells. | Q37700854 |
| | Regulation and functions of the IL-10 family of cytokines in inflammation and disease | Q37821924 |
| | Intestinal CD103+ dendritic cells: master regulators of tolerance? | Q37911701 |
| | The role of CD103⁺ dendritic cells in the intestinal mucosal immune system. | Q38008332 |
| | Skin-draining lymph nodes contain dermis-derived CD103(-) dendritic cells that constitutively produce retinoic acid and induce Foxp3(+) regulatory T cells | Q42830424 |
| | Tolerogenic dendritic cells generated with different immunosuppressive cytokines induce antigen-specific anergy and regulatory properties in memory CD4+ T cells. | Q43190647 |
| | 2010 report from the Center for International Blood and Marrow Transplant Research (CIBMTR): current uses and outcomes of hematopoietic cell transplants for blood and bone marrow disorders | Q44675985 |
| | Exacerbated graft-versus-host disease in Pirb-/- mice | Q44898070 |
| | Modified myeloid dendritic cells act as regulatory dendritic cells to induce anergic and regulatory T cells | Q44986020 |
| | Host dendritic cells alone are sufficient to initiate acute graft-versus-host disease | Q47371499 |
| | Naturally occurring regulatory dendritic cells regulate murine cutaneous chronic graft-versus-host disease. | Q51812010 |
| | Generation of therapeutic dendritic cells and regulatory T cells for preventing allogeneic cardiac graft rejection | Q56900558 |
| | "Alternatively activated" dendritic cells preferentially secrete IL-10, expand Foxp3+CD4+ T cells, and induce long-term organ allograft survival in combination with CTLA4-Ig | Q56901846 |
| | Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms | Q69490654 |
| | Prognostic factors for long-term survival in leukemic marrow recipients with special emphasis on age and prophylaxis for graft-versus-host disease | Q72131050 |
| | Regulatory dendritic cells protect mice from murine acute graft-versus-host disease and leukemia relapse | Q73153290 |
| | Enhanced graft-versus-host disease in older recipient mice following allogeneic bone marrow transplantation | Q73348826 |
| | Prevention of graft versus host disease by inactivation of host antigen-presenting cells | Q78016071 |
| | Donor APCs are required for maximal GVHD but not for GVL | Q80402910 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dendritic cell | Q506253 |
| P304 | page(s) | e75158 | |
| P577 | publication date | 2013-09-10 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Characterization of regulatory dendritic cells that mitigate acute graft-versus-host disease in older mice following allogeneic bone marrow transplantation | |
| P478 | volume | 8 | |